Hypoxia-suppressed Dicer and AGO1 promote angiogenesis Hypoxia-induced angiogenesis is a critical and complex process in normal development and disease conditions such as ischemia. In response to hypoxia, vascular endothelial cells (ECs) selectively upregulate a panel of angiogenic molecules through an intricately coordinated network consisting of transcriptional and post-transcriptional controls to support angiogenesis and new vessel formation. MicroRNAs (miRNAs or miRs) have emerged as essential regulators that modulate gene expression at post-transcriptional level. The regulatory mechanisms of miRNAs and their functional relevance have been intensively investigated in cardiovascular biology and other fields. Most studies to date have focused on transcriptional regulation of miRNAs and functional validation of single miRNA-single target pathways. I recently demonstrated that hypoxia induces a group of hypoxia-responsive miRNAs (HRMs) including Let-7 and miR-103/107, which jointly suppress Dicer and Argonaute 1 (AGO1), two key components of miRNA machinery. The marked decrease of Dicer and AGO1 indicate that hypoxia may cause a global reprogramming of miRNA biogenesis and targeting at post- transcriptional level. Gain- and loss-of-function experiments provide evidence that hypoxia- suppressed Dicer and AGO1 enhance expression of angiogenic factors in ECs, e.g. vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and placental growth factor (PlGF) and hence promote angiogenesis. Mechanistically, hypoxia-suppressed Dicer may alter miRNA biogenesis to promote selective processing of HRMs, which acts in concert with hypoxia- suppressed AGO1 to decrease the miRISC targeting of angiogenic molecules. These observations prompted me to hypothesize that hypoxia-suppressed Dicer and AGO1 alter miRNA biogenesis and miRNA targeting, which enhances the expression of genes promoting angiogenesis. To test this hypothesis, I proposed three specific aims:
In Aim 1, I will investigate the molecular basis by which the hypoxia-suppressed Dicer reprograms miRNA biogenesis in ECs to enhance the expression of angiogenic molecules.
In Aim 2, I will delineate the mechanism by which hypoxia- suppressed AGO1 regulates miRNA targetome in ECs to promote angiogenesis.
In Aim 3, I will examine the functional relevance of hypoxia-suppressed Dicer and AGO1 in pathological angiogenesis, i.e., in the context of myocardial ischemia. Collectively, these studies will reveal a new paradigm of miRNA-regulated gene expression in ECs responding to hypoxic and ischemic stress. Furthermore, the delineated pathways may provide novel insights into future translational studies involving pathological angiogenesis.

Public Health Relevance

Hypoxia (i.e. low oxygen conditions)-induced angiogenesis is a critical adaptation of vascular endothelial cells in development and many disease conditions, such as ischemia. The proposed study aims at elucidating a novel mechanism by which microRNAs, a novel group of gene regulators, and their processing proteins, mediate this functional change. The research project will enhance our understanding of hypoxia- related physiological changes and pathological progression, as well as provide new therapeutic opportunities in treating ischemic diseases, e.g. myocardial ischemia and peripheral vascular diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Transition Award (R00)
Project #
4R00HL122368-03
Application #
9377179
Study Section
Special Emphasis Panel (NSS)
Program Officer
Wang, Wayne C
Project Start
2017-02-06
Project End
2020-01-31
Budget Start
2017-02-06
Budget End
2018-01-31
Support Year
3
Fiscal Year
2017
Total Cost
$249,000
Indirect Cost
$65,471
Name
Beckman Research Institute/City of Hope
Department
Type
Research Institutes
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Miao, Yifei; Ajami, Nassim E; Huang, Tse-Shun et al. (2018) Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function. Nat Commun 9:292
Biase, Fernando H; Wu, Qiuyang; Calandrelli, Riccardo et al. (2018) Rainbow-Seq: Combining Cell Lineage Tracing with Single-Cell RNA Sequencing in Preimplantation Embryos. iScience 7:16-29
Allon, Michael; Litovsky, Silvio H; Tey, Jason Chieh Sheng et al. (2018) Abnormalities of vascular histology and collagen fiber configuration in patients with advanced chronic kidney disease. J Vasc Access :1129729818773305
Zhang, Jiao; Dong, Jianjie; Martin, Marcy et al. (2018) AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension. Am J Respir Crit Care Med 198:509-520
He, Ming; Chen, Zhen; Martin, Marcy et al. (2017) miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease. Circ Res 120:354-365
Guo, Wenjie; Liu, Wen; Chen, Zhen et al. (2017) Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis. Nat Commun 8:2168
Huang, Tse-Shun; Wang, Kuei-Chun; Quon, Sara et al. (2017) LINC00341 exerts an anti-inflammatory effect on endothelial cells by repressing VCAM1. Physiol Genomics 49:339-345
Shang, Fenqing; Wang, Shen-Chih; Hsu, Chien-Yi et al. (2017) MicroRNA-92a Mediates Endothelial Dysfunction in CKD. J Am Soc Nephrol 28:3251-3261
Ajami, Nassim E; Gupta, Shakti; Maurya, Mano R et al. (2017) Systems biology analysis of longitudinal functional response of endothelial cells to shear stress. Proc Natl Acad Sci U S A 114:10990-10995
Chen, Zhen; Li, Shuai; Subramaniam, Shankar et al. (2017) Epigenetic Regulation: A New Frontier for Biomedical Engineers. Annu Rev Biomed Eng 19:195-219

Showing the most recent 10 out of 11 publications